Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) Director Kathryn C. Zoon sold 1,830 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $8.35, for a total value of $15,280.50. Following the sale, the director now directly owns 49,971 shares of the company’s […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 7,720,000 shares, an increase of 9.8% from the June 15th total of 7,030,000 shares. Based on an average daily trading volume, of 1,470,000 […]
Emergent BioSolutions Inc (NYSE:EBS) Receives Average Recommendation of Hold from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) have earned a consensus rating of “Hold” from the five analysts that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Rating)’s share price shot up 6.2% during mid-day trading on Wednesday . The company traded as high as $9.96 and last traded at $9.93. 605,377 shares were traded during mid-day trading, a decline of 60% from the average session volume of 1,514,276 shares. The stock had previously closed at […]